These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2527118)
1. [Anorexigenic drugs: when, how and why]. Cairella M Clin Ter; 1989 May; 129(4):239-41. PubMed ID: 2527118 [No Abstract] [Full Text] [Related]
2. [Anorexigenic drugs in the treatment of obesity]. Maiz A; Kehr J; Grekin C; Reyes E; Charlín V; Fernández P; Manrique M; Velasco N Rev Med Chil; 1995 May; 123(5):637-40. PubMed ID: 8525212 [TBL] [Abstract][Full Text] [Related]
3. [Use of anorexigenic agents in obesity]. Tikhonova EP; Paleĭ AA Klin Med (Mosk); 1971 Oct; 49(10):79-83. PubMed ID: 5133159 [No Abstract] [Full Text] [Related]
4. [Treatment of obesity by a delayed-action anorexigenic agent checked by gas chromatography]. Junet R; Moayedi S Rev Med Suisse Romande; 1971 Jul; 91(7):503-10. PubMed ID: 5113316 [No Abstract] [Full Text] [Related]
5. [Treatment of obesity with a new lipolytic and anorexigenic drug: phenproporex]. Luquero Campos F Rev Esp Enferm Apar Dig; 1971 Apr; 34(1):91-8. PubMed ID: 5564856 [No Abstract] [Full Text] [Related]
6. [Clinical evaluation of a new anorexigenic agent]. Marrón JA; Arrieta F; Herrera JL Rev Clin Esp; 1970 Jul; 118(2):159-64. PubMed ID: 5486373 [No Abstract] [Full Text] [Related]
7. The treatment of obesity with Voranil (SU-10568), a new non-amphetamine anorexigenic agent. Rodos JJ J Am Osteopath Assoc; 1969 Oct; 69(2):161-4. PubMed ID: 5196055 [No Abstract] [Full Text] [Related]
8. [Clinical study of a current anorexigenic agent: T.D]. Plauchu M; Paffoy JC; Philippe LP; Nove-Josserand G; Chollet A; Valancogne C Lyon Med; 1972 Oct; 228(15):291-4. PubMed ID: 4639053 [No Abstract] [Full Text] [Related]
9. Neuro-ophthalmologic observations in obesity during anorexigenic (Desopimon-EGYT) treatment. Takács L Ther Hung; 1974; 22(4):176-9. PubMed ID: 4465962 [No Abstract] [Full Text] [Related]
10. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties. Elliott BW Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837 [No Abstract] [Full Text] [Related]
11. [Clinical study in 100 obese patients of a new anorexigenic agent active by the oral route: RO-4 5282]. Bricaire H; Philbert M Presse Med (1893); 1966 Dec; 74(52):2695-6. PubMed ID: 5924171 [No Abstract] [Full Text] [Related]
13. [Treatment of obesity. Results of various therapeutic procedures--current status. Drugs in the treatment of obesity]. Hepp KD Fortschr Med; 1988 May; 106(14):299-300. PubMed ID: 3402876 [No Abstract] [Full Text] [Related]
14. [Rôle of anorectic agents and other drugs in treatment of obesity]. Laurent LP Vie Med Can Fr; 1972 May; 1(5):491-3. PubMed ID: 4643642 [No Abstract] [Full Text] [Related]
15. The use of anorectic controlled drugs in bariatric practice. Phillips D J Ark Med Soc; 1979 Jun; 76(1):70-1. PubMed ID: 157352 [No Abstract] [Full Text] [Related]
16. [Pharmacological treatment of obesity. Drugs with predominantly anorectic action]. Ortensio A; Avagnina S; Costantino A Minerva Dietol Gastroenterol; 1988; 34(2):109-16. PubMed ID: 3050610 [No Abstract] [Full Text] [Related]
17. [Regulation of appetite in obese subjects by means of neutrotropic drugs]. Gamski M; Komarnicka R Pol Tyg Lek; 1968 Oct; 23(44):1688-90. PubMed ID: 5701464 [No Abstract] [Full Text] [Related]
19. [Present therapy of obesity: use of anoretic drugs]. de Medeiros Neto GA AMB Rev Assoc Med Bras; 1969 May; 15(5):235-8. PubMed ID: 5307357 [No Abstract] [Full Text] [Related]
20. [Human pharmacology of anorectics. Validity of a questionnaire on appetite]. Gagnon MA; Tétreault L Union Med Can; 1975 Jun; 104(6):922-9. PubMed ID: 1224411 [No Abstract] [Full Text] [Related] [Next] [New Search]